HS3ST3B1, which stands for Heparan Sulfate-Glucosamine 3-Sulfotransferase 3B1, is an enzyme involved in the intricate process of heparan sulfate (HS) biosynthesis. Heparan sulfates are complex linear polysaccharides attached to proteins, forming heparan sulfate proteoglycans (HSPGs) that are primarily located on the cell surface and in the extracellular matrix. These HSPGs play pivotal roles in various biological processes, including cell signaling, cell adhesion, and molecular filtration. The diversity and specificity of HS functions are primarily attributed to their highly heterogeneous structure, which is crafted through a series of enzymatic modifications. HS3ST3B1 contributes to this structural diversity by adding sulfate groups to specific positions on the heparan sulfate chains, affecting their interaction capabilities and biological functions.
Inhibitors targeting HS3ST3B1 would represent molecules tailored to modulate the enzymatic activity of HS3ST3B1, thereby influencing the sulfation pattern of heparan sulfates. By modulating HS3ST3B1 activity, one could alter the structure and, consequently, the function of heparan sulfates in the cell. Such modulation could impact a plethora of cellular processes reliant on the intricate interactions mediated by HSPGs. HS3ST3B1 inhibitors might include small molecules that bind directly to the enzyme's active site, preventing its catalytic activity. These molecules could be designed to mimic the enzyme's natural substrates or to bind to crucial residues essential for its catalytic action. Another strategy for inhibition might involve molecules that impact the expression or stability of HS3ST3B1, thereby influencing its availability and activity in the cell. Investigating the effects of HS3ST3B1 inhibition would offer insights into its specific roles in heparan sulfate biosynthesis, the broader functionalities and regulations associated with HSPGs, and the delicate balance of interactions that dictate the myriad biological processes mediated by these complex molecules. Understanding such nuances can shed light on the foundational principles governing cell-cell and cell-matrix interactions in various physiological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium chlorate | 7775-09-9 | sc-212938 | 100 g | $58.00 | 1 | |
Chlorate is a known inhibitor of cellular sulfation processes. By inhibiting sulfate uptake, it might reduce the substrate availability for HS3ST3B1. | ||||||
Sodium perchlorate, anhydrous | 7601-89-0 | sc-203398 sc-203398A sc-203398B | 100 g 500 g 2.5 kg | $65.00 $200.00 $615.00 | ||
Like chlorate, perchlorate can inhibit cellular sulfation by competing with sulfate uptake. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin has been shown to inhibit various sulfotransferases, although specificity for HS3ST3B1 needs validation. | ||||||
Mefenamic acid | 61-68-7 | sc-205380 sc-205380A | 25 g 100 g | $104.00 $204.00 | 6 | |
An NSAID that has been reported to inhibit some sulfotransferases. | ||||||
Daidzein | 486-66-8 | sc-24001 sc-24001A sc-24001B | 100 mg 500 mg 5 g | $25.00 $75.00 $150.00 | 32 | |
A phytoestrogen that can inhibit certain sulfotransferases. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $149.00 $210.00 $714.00 $2550.00 $10750.00 $21410.00 $40290.00 | 5 | |
An antiparasitic drug that may inhibit sulfotransferase activity. | ||||||